https://www.owkin.com https://www.owkin.com/about-us https://www.owkin.com/contact https://www.owkin.com/patient-data-network https://www.owkin.com/federated-learning https://www.owkin.com/careers https://www.owkin.com/people https://www.owkin.com/publications https://www.owkin.com/biomarkerplus https://www.owkin.com/drug-discovery-approach https://www.owkin.com/drug-development-approach https://www.owkin.com/humanity https://www.owkin.com/news https://www.owkin.com/diagnostics/rlapsrisk-bc https://www.owkin.com/videos https://www.owkin.com/patient-information https://www.owkin.com/drugmatch https://www.owkin.com/ai-ethics https://www.owkin.com/talent-supplier-guide https://www.owkin.com/candidate-guide https://www.owkin.com/a-z-of-ai-in-healthcare https://www.owkin.com/connect/downloads https://www.owkin.com/connect/k-pro-newsletter https://www.owkin.com/events https://www.owkin.com/press-kit https://www.owkin.com/blog-case-studies https://www.owkin.com/targetmatch https://www.owkin.com/pipeline/pipeline https://www.owkin.com/diagnostics/tls-detect https://www.owkin.com/search https://www.owkin.com/connect/mosaic https://www.owkin.com/connect/je-suis-elodie https://www.owkin.com/connect/glioblastoma-ai-hackathon https://www.owkin.com/pipeline/invoke https://www.owkin.com/diagnostics/our-products https://www.owkin.com/diagnostics/powering-precision-pathology https://www.owkin.com/diagnostics/next-gen-ai-dx https://www.owkin.com/diagnostics/msintuit-crc https://www.owkin.com/k-os/k-pro-free https://www.owkin.com/connect/thank-you https://www.owkin.com/pipeline/epkin https://www.owkin.com/connect/decoding-biology-hackathon https://www.owkin.com/k-os/k-pro https://www.owkin.com/k-os/what-is-agentic-ai https://www.owkin.com/connect/state-of-the-nation-biopharmas-agentic-ai-moment https://www.owkin.com/connect/book-a-demo https://www.owkin.com/diagnostics/destra https://www.owkin.com/k-os/k-pro-faq https://www.owkin.com/k-os/owkinzero https://www.owkin.com/connect/commission-a-report https://www.owkin.com/ai-scientist https://www.owkin.com/what-is-patient-validation https://www.owkin.com/data-licensing https://www.owkin.com/k-os/distribution-partner https://www.owkin.com/publications/a-benchmark-of-computational-pipelines-for-single-cell-histone-modification-data https://www.owkin.com/publications/a-deep-learning-based-multiscale-integration-of-spatial-omics-with-tumor-morphology https://www.owkin.com/publications/a-deep-learning-method-for-predicting-knee-osteoarthritis-radiographic-progression-from-mri https://www.owkin.com/publications/a-deep-learning-model-to-predict-rna-seq-expression-of-tumours-from-whole-slide-images https://www.owkin.com/publications/a-statistical-learning-take-on-the-concordance-index-for-survival-analysis https://www.owkin.com/publications/abdominal-musculature-segmentation-and-surface-prediction-from-ct-using-deep-learning-for-sarcopenia-assessment https://www.owkin.com/publications/adjuvant-endocrine-therapy-uptake-toxicity-quality-of-life-and-prediction-of-early-discontinuation https://www.owkin.com/publications/ai-allows-pre-screening-of-fgfr3-mutational-status-using-routine-histology-slides-of-muscle-invasive-bladder-cancer https://www.owkin.com/publications/an-artificial-intelligence-model-predicts-the-survival-of-solid-tumour-patients-from-imaging-and-clinical-data https://www.owkin.com/publications/blind-validation-of-msintuit-an-ai-based-pre-screening-tool-for-msi-detection-from-histology-slides-of-colorectal-cancer https://www.owkin.com/publications/brain-age-prediction-of-healthy-subjects-on-anatomic-mri-with-deep-learning-going-beyond-with-an-explainable-ai https://www.owkin.com/publications/can-ai-scientist-agents-learn-from-lab-in-the-loop-feedback-evidence-from-iterative-perturbation-discovery https://www.owkin.com/publications/can-machine-learning-bring-cardiovascular-risk-assessment-to-the-next-level-a-methodological-study-using-fourier-trial-data https://www.owkin.com/publications/carmil-context-aware-regularization-on-multiple-instance-learning-models-for-whole-slide-images https://www.owkin.com/publications/classification-and-disease-localization-in-histopathology-using-only-global-labels-a-weakly-supervised-approach https://www.owkin.com/publications/clinical-validation-of-rlapsrisk-bc-in-an-international-multi-cohorts-setting https://www.owkin.com/publications/collaborative-federated-learning-behind-hospitals-firewalls-for-predicting-histological-response-to-neoadjuvant-chemotherapy-in-triple-negative-breast-cancer https://www.owkin.com/publications/combining-a-deep-learning-model-with-clinical-data-better-predicts-hepatocellular-carcinoma-behavior-following-surgery https://www.owkin.com/publications/comparative-performances-of-machine-learning-methods-for-classifying-crohn-disease-patients-using-genome-wide-genotyping-data https://www.owkin.com/publications/comprehensive-molecular-and-pathologic-evaluation-of-transitional-mesothelioma-assisted-by-deep-learning-approach-a-multi-institutional-study-of-the-international-mesothelioma-panel-from-the-mesopath-reference-center https://www.owkin.com/publications/cytosyn-a-foundation-diffusion-model-for-histopathology-tech-report https://www.owkin.com/publications/deciphering-cellular-ecosystems-driving-tumor-progression-and-immune-escape-from-spatial-transcriptomics-and-single-cell-with-compotes https://www.owkin.com/publications/deep-learning-assessment-of-metastatic-relapse-risk-from-digitized-breast-cancer-histological-slides https://www.owkin.com/publications/deep-learning-based-classification-of-mesothelioma-improves-prediction-of-patient-outcome https://www.owkin.com/publications/deep-learning-on-histologic-slides-accurately-predicts-consensus-molecular-subtypes-and-spatial-heterogeneity-in-colon-cancer https://www.owkin.com/publications/deep-learning-predicts-patients-outcome-and-mutations-from-digitized-histology-slides-in-gastrointestinal-stromal-tumor https://www.owkin.com/publications/deep-learning-uncovers-histological-patterns-of-yap1-tead-activity-related-to-disease-aggressiveness-in-cancer-patients https://www.owkin.com/publications/detection-and-characterization-of-mri-breast-lesions-using-deep-learning https://www.owkin.com/publications/deterministic-and-generalized-framework-for-unsupervised-learning-with-restricted-boltzmann-machines-2 https://www.owkin.com/publications/development-of-a-deep-learning-model-tailored-for-her2-detection-in-breast-cancer-to-aid-pathologists-in-interpreting-her2-low-cases https://www.owkin.com/publications/diagnosis-of-focal-liver-lesions-from-ultrasound-using-deep-learning https://www.owkin.com/publications/differentially-private-federated-learning-for-cancer-prediction https://www.owkin.com/publications/distilling-foundation-models-for-robust-and-efficient-models-in-digital-pathology https://www.owkin.com/publications/efficient-per-example-gradient-computations-in-convolutional-neural-networks https://www.owkin.com/publications/external-control-arm-analysis-an-evaluation-of-propensity-score-approaches-g-computation-and-doubly-debiased-machine-learning https://www.owkin.com/publications/fedeca-a-federated-external-control-arm-method-for-causal-inference-with-time-to-event-data-in-distributed-settings https://www.owkin.com/publications/federated-learning-for-predicting-histological-response-to-neoadjuvant-chemotherapy-in-triple-negative-breast-cancer https://www.owkin.com/publications/federated-survival-analysis-with-discrete-time-cox-models https://www.owkin.com/publications/fedpydeseq2-a-federated-framework-for-bulk-rna-seq-differential-expression-analysis https://www.owkin.com/publications/flamby-datasets-and-benchmarks-for-cross-silo-federated-learning-in-realistic-healthcare-settings https://www.owkin.com/publications/fully-automatic-segmentation-of-diffuse-large-b-cell-lymphoma-lesions-on-3d-fdg-pet-ct-for-total-metabolic-tumour-volume-prediction-using-a-convolutional-neural-network https://www.owkin.com/publications/histology-and-spatial-transcriptomic-integration-revealed-infiltration-zone-with-specific-cell-composition-as-a-prognostic-hotspot-in-glioblastoma https://www.owkin.com/publications/how-to-estimate-the-age-of-your-brain-with-mri-data https://www.owkin.com/publications/identification-of-pancreatic-adenocarcinoma-molecular-subtypes-on-histology-slides-using-deep-learning-models https://www.owkin.com/publications/imilia-interpretable-multiple-instance-learning-for-inflammation-prediction-in-ibd-from-h-e-whole-slide-images https://www.owkin.com/publications/industry-scale-orchestrated-federated-learning-for-drug-discovery-2 https://www.owkin.com/publications/integrating-deep-learning-ct-scan-model-biological-and-clinical-variables-to-predict-severity-of-covid-19-patients https://www.owkin.com/publications/joint-probabilistic-modeling-of-pseudobulk-and-single-cell-transcriptomics-enables-accurate-estimation-of-cell-type-composition https://www.owkin.com/publications/legitimate-ground-truth-free-metrics-for-deep-uncertainty-classification-scoring https://www.owkin.com/publications/more-efficient-and-inclusive-time-to-event-trials-with-covariate-adjustment-a-simulation-study https://www.owkin.com/publications/mosaic-intra-tumoral-heterogeneity-characterization-through-large-scale-spatial-and-cell-resolved-multi-omics-profiling https://www.owkin.com/publications/multi-modal-benchmarking-of-the-ultima-ug100-and-illumina-novaseq-sequencing-platforms-using-clinically-relevant-ffpe-tissues https://www.owkin.com/publications/multimodal-machine-learning-models-enhance-outcome-prediction-in-intrahepatic-cholangiocarcinoma https://www.owkin.com/publications/multimodal-prediction-of-metastatic-relapse-using-federated-deep-learning-in-soft-tissue-sarcoma-with-a-complex-genomic-profile https://www.owkin.com/publications/multiomic-analysis-of-malignant-pleural-mesothelioma-identifies-molecular-axes-and-specialized-tumor-profiles-driving-intertumor-heterogeneity https://www.owkin.com/publications/multiple-instance-learning-with-spatial-transcriptomics-for-interpretable-patient-level-predictions-application-in-glioblastoma https://www.owkin.com/publications/myc-rearrangement-prediction-from-lysa-whole-slide-images-in-large-b-cell-lymphoma-a-multi-centric-validation-of-self-supervised-deep-learning-models https://www.owkin.com/publications/okn4395-a-first-in-class-ep2-ep4-dp1-triple-antagonist-reprograms-prostanoid-driven-immunosuppression-to-restore-antitumor-immunity https://www.owkin.com/publications/owkins-jean-philippe-vert-shared-his-thoughts-on-how-generative-ai-might-disrupt-drug-discovery-with-nature-biotechnology https://www.owkin.com/publications/owkinzero-accelerating-biological-discovery-with-ai https://www.owkin.com/publications/pacpaint-a-histology-based-deep-learning-model-uncovers-the-extensive-intratumor-molecular-heterogeneity-of-pancreatic-adenocarcinoma https://www.owkin.com/publications/phikon-v2-a-large-and-public-feature-extractor-for-biomarker-prediction https://www.owkin.com/publications/predicting-gene-essentiality-and-drug-response-from-perturbation-screens-in-preclinical-cancer-models-with-leap-layered-ensemble-of-autoencoders-and-predictors https://www.owkin.com/publications/predicting-survival-after-hepatocellular-carcinoma-resection-using-deep-learning-on-histological-slides https://www.owkin.com/publications/prediction-of-distant-relapse-in-patients-with-invasive-breast-cancer-from-deep-learning-models-applied-to-digital-pathology-slides https://www.owkin.com/publications/prescription-of-off-label-medications-in-patients-on-dialysis-time-to-challenge-contraindications https://www.owkin.com/publications/prognostic-value-of-anthropometric-measures-extracted-from-whole-body-ct-using-deep-learning-in-patients-with-non-small-cell-lung-cancer https://www.owkin.com/publications/pydeseq2-a-python-package-for-bulk-rna-seq-differential-expression-analysis https://www.owkin.com/publications/response-heterogeneity-as-a-new-biomarker-of-treatment-response-in-patients-with-neuroendocrine-tumors https://www.owkin.com/publications/robust-detection-of-covariate-treatment-interactions-in-clinical-trials https://www.owkin.com/publications/robust-evaluation-of-deep-learning-based-representation-methods-for-survival-and-gene-essentiality-prediction-on-bulk-rna-seq-data https://www.owkin.com/publications/robust-sensitivity-control-in-digital-pathology-via-tile-score-distribution-matching https://www.owkin.com/publications/safer-sparse-secure-aggregation-for-federated-learning https://www.owkin.com/publications/scaling-self-supervised-learning-for-histopathology-with-masked-image-modeling https://www.owkin.com/publications/securefedyj-a-safe-feature-gaussianization-protocol-for-federated-learning https://www.owkin.com/publications/self-supervised-learning-improves-dmmr-msi-detection-from-histology-slides-across-multiple-cancers https://www.owkin.com/publications/self-supervision-closes-the-gap-between-weak-and-strong-supervision-in-histology https://www.owkin.com/publications/semiautomated-segmentation-of-hepatocellular-carcinoma-tumors-with-mri-using-convolutional-neural-networks https://www.owkin.com/publications/siloed-federated-learning-for-multi-centric-histopathology-datasets https://www.owkin.com/publications/spatially-integrated-multi-omics-reveals-the-multicellular-landscape-of-progenitor-driven-glioblastoma-progression https://www.owkin.com/publications/sratta-sample-re-attribution-attack-of-secure-aggregation-in-federated-learning https://www.owkin.com/publications/subgroup-analysis-methods-for-time-to-event-outcomes-in-heterogeneous-randomized-controlled-trials https://www.owkin.com/publications/substra-a-framework-for-privacy-preserving-traceable-and-collaborative-machine-learning https://www.owkin.com/publications/the-future-of-digital-health-with-federated-learning https://www.owkin.com/publications/the-use-of-deep-learning-models-to-predict-progression-free-survival-in-patients-with-neuroendocrine-tumors https://www.owkin.com/publications/towards-comprehensive-cellular-characterisation-of-h-e-slides https://www.owkin.com/publications/toxicblend-virtual-screening-of-toxic-compounds-with-ensemble-predictors https://www.owkin.com/publications/transcriptome-analysis-of-archived-tumor-tissues-by-visium-geomx-dsp-and-chromium-methods-reveals-inter--and-intra-patient-heterogeneity https://www.owkin.com/publications/using-stylegan-for-visual-interpretability-of-deep-learning-models-on-medical-images https://www.owkin.com/policies/code-of-conduct https://www.owkin.com/policies/cookie-policy https://www.owkin.com/policies/credits https://www.owkin.com/policies/privacy-policy https://www.owkin.com/policies/supplier-code-of-conduct https://www.owkin.com/policies/terms-of-use https://www.owkin.com/humanity/biostatistician-at-gustave-roussy https://www.owkin.com/humanity/catherine-cerisey https://www.owkin.com/humanity/clara-bechet https://www.owkin.com/humanity/dean-fennell https://www.owkin.com/humanity/eric-oermann https://www.owkin.com/humanity/jessica-morley https://www.owkin.com/humanity/miriam-merad https://www.owkin.com/humanity/olivier-elemento https://www.owkin.com/showcase-testimonials/alan-spatz-m-d https://www.owkin.com/showcase-testimonials/anthony-magliocco https://www.owkin.com/showcase-testimonials/antoine-italiano-md-phd https://www.owkin.com/showcase-testimonials/antoine-italiano-md-phd-2 https://www.owkin.com/showcase-testimonials/ari-rao-m-d-ph-d https://www.owkin.com/showcase-testimonials/ben-mellows https://www.owkin.com/showcase-testimonials/catherine-guettier-md-phd https://www.owkin.com/showcase-testimonials/charlotte-spencer https://www.owkin.com/showcase-testimonials/doctor-frederik-deman https://www.owkin.com/showcase-testimonials/doctor-isabelle-birtwisle-peyrottes https://www.owkin.com/showcase-testimonials/doctor-roberto-salgado https://www.owkin.com/showcase-testimonials/dr-ingo-ringshausen https://www.owkin.com/showcase-testimonials/frank-nestle https://www.owkin.com/showcase-testimonials/katharina-von-loga https://www.owkin.com/showcase-testimonials/kristina-rodnikova https://www.owkin.com/showcase-testimonials/pr-fabrice-andre https://www.owkin.com/showcase-testimonials/pr-fabrice-andre-2 https://www.owkin.com/showcase-testimonials/pr-franck-bielle https://www.owkin.com/showcase-testimonials/pr-marc-sanson https://www.owkin.com/showcase-testimonials/prof-jerome-cros https://www.owkin.com/showcase-testimonials/prof-nicolas-girard-md-phd https://www.owkin.com/showcase-testimonials/professor-fabrice-andre-md-phd https://www.owkin.com/showcase-testimonials/professor-frederic-bibeau https://www.owkin.com/showcase-testimonials/professor-galateau-salle https://www.owkin.com/showcase-testimonials/professor-jean-christophe-sabourin https://www.owkin.com/showcase-testimonials/professor-miriam-merad https://www.owkin.com/showcase-testimonials/rick-peng https://www.owkin.com/showcase-testimonials/scott-k-pruitt https://www.owkin.com/showcase-testimonials/sean-khozin https://www.owkin.com/showcase-testimonials/sheeba-irshad-md-phd https://www.owkin.com/showcase-testimonials/shehzad-z-sheikh-m-d-ph-d https://www.owkin.com/showcase-testimonials/thierry-durand https://www.owkin.com/newsfeed/10-ways-to-build-a-more-intelligent-future https://www.owkin.com/newsfeed/13-techbio-startups-investors-are-keeping-an-eye-on https://www.owkin.com/newsfeed/absci-and-owkin-synergize-leading-techbio-platforms-to-advance-generative-ai-drug-discovery https://www.owkin.com/newsfeed/ai-and-multimodal-patient-data-for-better-faster-clinical-trials https://www.owkin.com/newsfeed/ai-biotech-unicorn-owkin-is-one-step-closer-to-using-ai-to-boost-drug-discovery https://www.owkin.com/newsfeed/ai-in-drug-discovery-overcoming-the-data-issue https://www.owkin.com/newsfeed/ai-predicts-the-risk-of-recurrence-for-women-with-the-most-common-breast-cancer https://www.owkin.com/newsfeed/alphabets-gv-inks-5m-investment-in-owkin-for-its-series-a https://www.owkin.com/newsfeed/artificial-intelligence-a-year-of-collaboration-between-gustave-roussy-institute-and-owkin https://www.owkin.com/newsfeed/artificial-intelligence-in-oncology-strategic-alliance-between-owkin-and-gustave-roussy-formed-to-accelerate-clinical-research https://www.owkin.com/newsfeed/as-europe-aims-for-digital-sovereignty-biomedical-agentic-ai-could-be-the-next-big-field https://www.owkin.com/newsfeed/asco-2021-owkin-and-ap-hp-present-their-new-ai-based-tool-to-improve-pancreatic-cancer-research-and-treatment https://www.owkin.com/newsfeed/aster-insights-and-owkin-collaborate-to-accelerate-research-in-breast-cancer https://www.owkin.com/newsfeed/bbc-news-features-owkins-ai-breast-cancer-diagnostic-tool https://www.owkin.com/newsfeed/bfm-business-interviews-owkins-coo-alban-de-la-sabliere-on-how-ai-is-transforming-healthcare https://www.owkin.com/newsfeed/big-picture-a-new-consortium-of-the-eu-innovative-medicines-initiative-imi-will-establish-the-biggest-database-of-pathology-images-to-accelerate-the-development-of-artificial-intelligence-in-medicine https://www.owkin.com/newsfeed/bio-spain-interviews-owkins-principal-partnerships-manager-on-the-potential-of-ai-to-revolutionize-healthcare-in-spain https://www.owkin.com/newsfeed/bioptimus-la-start-up-francaise-qui-veut-devenir-le-chatgpt-de-la-biologie https://www.owkin.com/newsfeed/bioptimus-nabs-35m-to-accelerate-biology-research-with-ai https://www.owkin.com/newsfeed/bioptimus-raises-35-million-seed-round-to-develop-ai-foundational-model-focused-on-biology https://www.owkin.com/newsfeed/business-insider-names-owkin-one-of-the-healthcare-and-biotech-startups-to-watch-in-2023 https://www.owkin.com/newsfeed/business-next-features-owkin-about-accelerating-drug-discovery https://www.owkin.com/newsfeed/camille-marini-cto-of-owkin-on-the-need-for-diversity-in-the-tech-industry https://www.owkin.com/newsfeed/can-pharma-trust-the-new-wave-of-agentic-ai https://www.owkin.com/newsfeed/co-founder-and-ceo-thomas-clozel-shares-his-vision-for-owkin-in-le-monde https://www.owkin.com/newsfeed/condor-an-owkin-precision-medicine-project-is-awarded-a-eu10m-rhu-grant https://www.owkin.com/newsfeed/evotec-and-owkin-enter-an-ai-powered-strategic-partnership-to-accelerate-therapeutics-pipeline-in-oncology-and-i-i https://www.owkin.com/newsfeed/ex-sanofis-global-head-of-partnering-aims-to-position-owkin-as-the-industry-leader https://www.owkin.com/newsfeed/fast-company-features-owkins-ceo-thomas-clozel-about-the-mounting-pressure-on-researchers-as-funding-cuts-continue https://www.owkin.com/newsfeed/fast-company-features-owkins-ceo-thomas-clozel-on-artificial-superintelligence-for-biology https://www.owkin.com/newsfeed/federated-learning-the-future-of-data-driven-medicine https://www.owkin.com/newsfeed/fierce-medtech-names-owkin-as-one-of-its-fierce-15-med-tech-companies-of-2021 https://www.owkin.com/newsfeed/first-ai-based-tool-for-predicting-genomic-subtypes-of-pancreatic-cancer-pdac-shared-at-asco-2021-groundbreaking-science-from-ap-hp-greater-paris-university-hospitals-and-owkin-collaboration https://www.owkin.com/newsfeed/france-24-covers-owkins-glioblastoma-ai-hackathon https://www.owkin.com/newsfeed/french-ey-features-owkins-ceo-thomas-clozel-in-the-grow-fast-now-what-podcast https://www.owkin.com/newsfeed/french-owkin-setting-the-standard-for-ai-in-biology https://www.owkin.com/newsfeed/french-tech-owkin-is-redefining-the-world-of-ai https://www.owkin.com/newsfeed/french-techbio-owkin-turns-biotech-on-its-head-thanks-to-artificial-intelligence https://www.owkin.com/newsfeed/french-thomas-clozel-in-10-years-we-will-have-replaced-big-pharma https://www.owkin.com/newsfeed/generative-ai-deployment-report-strategies-for-smooth-scaling https://www.owkin.com/newsfeed/global-ai-impact-summit-2026-india-owkin-strengthens-its-strategic-partnerships-with-india-to-advance-biological-artificial-super-intelligence https://www.owkin.com/newsfeed/google-deepmind-alumni-unveil-bioptimus-aiming-to-build-first-universal-biology-ai-model https://www.owkin.com/newsfeed/groundbreaking-new-method-enables-secure-collaborative-cancer-research-across-borders https://www.owkin.com/newsfeed/gustave-roussy-and-owkin-use-ai-to-predict-the-relapse-risk-of-breast-cancer-patients https://www.owkin.com/newsfeed/healthchain-owkins-collaborative-research-project-takes-the-spotlight-in-unicancer-unitrad-group-and-centre-leon-berards-webinar https://www.owkin.com/newsfeed/how-ai-is-helping-to-treat-her2-low-breast-cancer-patients https://www.owkin.com/newsfeed/how-ai-is-reshaping-the-pharmaceutical-industry https://www.owkin.com/newsfeed/how-data-driven-approaches-to-covariate-adjustment-help-de-risk-and-accelerate-clinical-trials https://www.owkin.com/newsfeed/how-owkin-trains-ai-models-without-transferring-data-with-federated-learning https://www.owkin.com/newsfeed/how-techbio-is-disrupting-the-pharma-industry https://www.owkin.com/newsfeed/ia-et-sante-lap-hp-renouvelle-son-accord-avec-owkin-pour-accelerer-linnovation-ia-au-service-des-patients https://www.owkin.com/newsfeed/improving-patient-outcomes-with-a-comprehensive-diagnostic-approach-developed-by-owkin https://www.owkin.com/newsfeed/inserm-and-owkin-sign-an-agreement-to-facilitate-access-to-artificial-intelligence-for-researchers https://www.owkin.com/newsfeed/interviewing-anna-huyghues-despointes-owkins-chief-corporate-development-officer https://www.owkin.com/newsfeed/investors-are-betting-big-on-ai-start-ups-to-accelerate-drug-development https://www.owkin.com/newsfeed/jean-jacques-bienaime-appointed-chairman-of-the-board-at-owkin https://www.owkin.com/newsfeed/jerome-pesenti-entrepreneur-and-former-head-of-ai-at-meta-joins-owkins-board-of-directors https://www.owkin.com/newsfeed/la-licorne-owkin-accelere-dans-la-medecine-de-precision https://www.owkin.com/newsfeed/la-startup-bioptimus-melant-biologie-et-ia-se-lance-apres-avoir-leve-35-millions-de-dollars https://www.owkin.com/newsfeed/leading-ai-medical-innovator-sean-khozin-joins-owkin-as-an-impact-advisor https://www.owkin.com/newsfeed/learn-about-ai-and-federated-learning-in-biomedical-research-in-the-midas-owkin-workshop https://www.owkin.com/newsfeed/les-echos-covers-owkins-role-in-ai-in-healthcare-for-the-ai-action-summit https://www.owkin.com/newsfeed/les-echos-features-owkin-as-a-key-ai-partner-for-pharma https://www.owkin.com/newsfeed/lhopital-bicetre-ap-hp-integre-une-solution-dia-de-owkin-pour-ameliorer-la-prediction-des-rechutes-du-cancer-du-sein https://www.owkin.com/newsfeed/major-study-validates-owkins-best-in-class-ai-diagnostic-for-colorectal-cancer-biomarker-aimed-at-optimizing-patient-access-to-immunotherapy https://www.owkin.com/newsfeed/melloddy-project-meets-its-year-one-objective-deployment-of-t-he-worlds-first-secure-platform-for-multi-task-federated-learning-in-drug-discovery https://www.owkin.com/newsfeed/melloddy-releases-its-second-year-results-improved-model-performance-using-federated-learning-in-drug-discovery https://www.owkin.com/newsfeed/nature-communications-publishes-pacpaint-a-new-histology-based-deep-learning-model-to-decode-the-complexity-of-pancreatic-cancer https://www.owkin.com/newsfeed/nature-medicine-publishes-breakthrough-owkin-research-on-the-first-ever-use-of-federated-learning-to-train-deep-learning-models-on-multiple-hospitals-histopathology-data https://www.owkin.com/newsfeed/navigating-the-micro-and-macro-realms-of-biology-through-spatial-omics-and-ai https://www.owkin.com/newsfeed/nhs-lothian-joins-owkins-patient-data-network-with-multi-year-partnership https://www.owkin.com/newsfeed/nhs-trust-and-owkin-to-develop-ai-tool-to-combat-her2-breast-cancer https://www.owkin.com/newsfeed/on-bbc-radio-5-live-owkin-co-founder-and-ceo-thomas-clozel-explains-our-new-ai-project-to-better-detect-her2-positive-breast-cancer https://www.owkin.com/newsfeed/optima-new-research-project-aims-to-improve-treatment-for-patients-with-prostate-breast-and-lung-cancer-through-ai https://www.owkin.com/newsfeed/owkin-advances-frontier-model-development-for-biological-artificial-super-intelligence-accelerated-by-nvidia https://www.owkin.com/newsfeed/owkin-ai-diagnostic-solutions-for-identifying-breast-colorectal-cancer-types-are-approved-for-use-in-the-eu https://www.owkin.com/newsfeed/owkin-and-12-partners-launch-14-million-nih-project-to-allow-doctors-to-spot-cancer-depression-and-other-diseases-from-the-human-voice https://www.owkin.com/newsfeed/owkin-and-adc-therapeutics-to-build-ai-models-to-improve-hematologic-cancer-treatment https://www.owkin.com/newsfeed/owkin-and-amgen-use-ai-to-improve-cardiovascular-risk-prediction https://www.owkin.com/newsfeed/owkin-and-arkhn-join-forces-with-inria-to-make-oncology-data-accessible https://www.owkin.com/newsfeed/owkin-and-cancerlinq-collaborate-to-use-federated-learning-on-real-world-oncology-data-in-a-study-to-understand-lung-cancer-treatment https://www.owkin.com/newsfeed/owkin-and-cerba-path-collaborate-to-transform-breast-and-colorectal-cancer-diagnosis-through-integration-of-artificial-intelligence-powered-tests-into-standard-clinical-practice https://www.owkin.com/newsfeed/owkin-and-cleveland-clinic-develop-an-artificial-intelligence-model-that-predicts-liver-cancer-prognosis https://www.owkin.com/newsfeed/owkin-and-evotec-partner-to-accelerate-therapeutics-in-oncology-and-i-i https://www.owkin.com/newsfeed/owkin-and-finnish-biobanks-collaborate-to-advance-medical-research https://www.owkin.com/newsfeed/owkin-and-institut-carnot-calym-launch-a-collaboration-to-advance-lymphoma-research-with-ai https://www.owkin.com/newsfeed/owkin-and-nantes-university-hospital-chu-nantes-to-advance-cancer-research-with-artificial-intelligence https://www.owkin.com/newsfeed/owkin-and-newcastle-upon-tyne-hospitals-nhs-foundation-trust-announce-five-year-ai-partnership-to-accelerate-medical-discovery https://www.owkin.com/newsfeed/owkin-and-nyu-langone-health-to-advance-non-small-cell-lung-cancer-research-with-ai https://www.owkin.com/newsfeed/owkin-and-proscia-expand-access-to-ai-pre-screening-for-colorectal-cancer-patients https://www.owkin.com/newsfeed/owkin-and-the-bergonie-institute-sign-further-collaboration-agreements-with-cancer-research-centers-in-immuno-oncology-and-sarcoma https://www.owkin.com/newsfeed/owkin-and-the-comprehensive-cancer-center-of-the-medical-university-of-vienna-announce-strategic-collaboration-to-accelerate-cancer-research-and-care-with-ai-copilot https://www.owkin.com/newsfeed/owkin-and-the-university-of-pittsburgh-launch-a-collaboration-to-advance-cancer-research-with-ai-and-fl https://www.owkin.com/newsfeed/owkin-and-tribun-health-launch-strategic-partnership-to-accelerate-access-to-ai-solutions-for-diagnosis-and-pharma-research https://www.owkin.com/newsfeed/owkin-and-university-hospitals-birmingham-collaborate-to-use-ai-diagnostics-in-a-study-that-may-diagnose-and-help-treat-colorectal-cancer-quicker https://www.owkin.com/newsfeed/owkin-announces-a-new-collaboration-to-identify-high-immunogenic-epitopes-and-candidates-for-covid-19-and-coronaviruses-future-vaccines https://www.owkin.com/newsfeed/owkin-announces-availability-of-k-pro-in-the-new-aws-marketplace-ai-agents-and-tools-category https://www.owkin.com/newsfeed/owkin-announces-first-patient-dosed-in-phase-1-clinical-trial-of-okn4395 https://www.owkin.com/newsfeed/owkin-announces-international-validation-results-of-brcaura-ai-driven-screening-for-gbrca-mutations-directly-from-pathology-slides https://www.owkin.com/newsfeed/owkin-announces-its-new-machine-learning-model-to-predict-covid-19-severity https://www.owkin.com/newsfeed/owkin-announces-msintuit-r-crc-v2-a-next-generation-ai-diagnostic-aimed-at-transforming-the-detection-and-treatment-of-colorectal-cancer https://www.owkin.com/newsfeed/owkin-announces-multi-year-clinical-data-science-strategic-collaboration-with-bristol-myers-squibb https://www.owkin.com/newsfeed/owkin-announces-new-scientific-advisory-board-chaired-by-world-leading-precision-oncologist https://www.owkin.com/newsfeed/owkin-announces-owkin-k1-0-turbigo https://www.owkin.com/newsfeed/owkin-announces-partnership-with-astrazeneca-to-develop-an-ai-gbrca-pre-screen-solution-for-breast-cancer https://www.owkin.com/newsfeed/owkin-announces-partnership-with-consensus-to-strengthen-literature-intelligence-for-owkins-ai-scientist-k-pro https://www.owkin.com/newsfeed/owkin-appoints-biotech-leader-andreas-emmenegger-as-chief-financial-officer https://www.owkin.com/newsfeed/owkin-appoints-data-science-pioneer-jean-philippe-vert-as-chief-research-and-development-officer https://www.owkin.com/newsfeed/owkin-appoints-ex-googler-vert-as-chief-r-d-officer https://www.owkin.com/newsfeed/owkin-appoints-graeme-bell-as-chief-financial-officer https://www.owkin.com/newsfeed/owkin-appoints-sanofis-bd-global-head-of-partnering-as-cbo https://www.owkin.com/newsfeed/owkin-appoints-sanofis-global-head-of-partnering-alban-de-la-sabliere-as-chief-business-officer https://www.owkin.com/newsfeed/owkin-as-an-example-of-building-healthcare-ai-in-europes-strict-regulatory-environment https://www.owkin.com/newsfeed/owkin-becomes-the-latest-french-unicorn-after-a-180m-investment-from-sanofi https://www.owkin.com/newsfeed/owkin-becomes-unicorn-with-180m-investment-from-sanofi-and-four-new-collaborative-projects https://www.owkin.com/newsfeed/owkin-bolsters-the-senior-team-with-experienced-pharma-executives-to-expand-the-platform-and-strategic-partnerships https://www.owkin.com/newsfeed/owkin-brings-biology-super-intelligence-closer-to-reality-with-new-ai-infrastructure-for-biological-breakthroughs https://www.owkin.com/newsfeed/owkin-co-founder-to-argue-for-a-refocusing-of-ais-role-in-medical-research-at-the-40th-annual-j-p-morgan-healthcare-conference https://www.owkin.com/newsfeed/owkin-collaborates-with-msd-to-assess-the-impact-of-msintuit-r-crc-to-accelerate-patient-identification-for-therapeutic-decisions https://www.owkin.com/newsfeed/owkin-collaborates-with-stanford-medicine-on-lung-cancer-and-mesothelioma-treatment-research-using-ai https://www.owkin.com/newsfeed/owkin-collaborates-with-uk-hospitals-to-turbocharge-ai-breast-cancer-diagnosis https://www.owkin.com/newsfeed/owkin-creates-new-spin-out-waiv-formerly-owkin-dx-with-33m-financing https://www.owkin.com/newsfeed/owkin-demonstrates-commitment-to-utmost-quality-with-its-ai-solutions-for-digital-pathology-with-iso-certification https://www.owkin.com/newsfeed/owkin-enters-collaboration-agreement-with-msd-to-develop-ai-powered-diagnostics-for-cancer https://www.owkin.com/newsfeed/owkin-enters-into-agreement-to-build-innovative-methods-with-the-potential-to-enhance-ai-enabled-external-control-arms https://www.owkin.com/newsfeed/owkin-enters-into-collaboration-agreement-with-msd-to-develop-ai-based-diagnostics-for-cancer https://www.owkin.com/newsfeed/owkin-expands-collaboration-with-sanofi-leveraging-ai-for-drug-positioning-in-immunology https://www.owkin.com/newsfeed/owkin-expands-reach-of-ai-diagnostic-for-colorectal-cancer-through-integration-with-sectra https://www.owkin.com/newsfeed/owkin-featured-in-top-ai-startups-transforming-dissemination-of-biomedical-science-authors https://www.owkin.com/newsfeed/owkin-has-been-named-one-of-forbes-ai-50 https://www.owkin.com/newsfeed/owkin-identified-biomarker-defined-patient-subgroups-in-phase-2-trial-data-will-be-retrospectively-assessed-by-servier https://www.owkin.com/newsfeed/owkin-in-nature-biopharma-dealmakers-at-the-forefront-of-using-ai-to-accelerate-medical-research https://www.owkin.com/newsfeed/owkin-is-named-in-sifteds-top-20-french-ai-startups-to-watch https://www.owkin.com/newsfeed/owkin-is-named-one-of-the-top-10-most-funded-ai-healthcare-startups https://www.owkin.com/newsfeed/owkin-is-opening-a-new-office-in-basel-switzerland https://www.owkin.com/newsfeed/owkin-joins-the-gaia-x-european-association-to-contribute-to-a-sustainable-european-data-ecosystem https://www.owkin.com/newsfeed/owkin-lance-portrait-un-consortium-pour-faire-de-la-france-un-leader-mondial-dans-lutilisation-de-lia-pour-diagnostiquer-et-traiter-les-maladies https://www.owkin.com/newsfeed/owkin-launches-atlantis-an-extensive-multimodal-data-mapping-initiative https://www.owkin.com/newsfeed/owkin-launches-in-spain-with-fundacion-para-la-investigacion-biomedica-del-hospital-universitario-ramon-y-cajal-bringing-leading-edge-ai-to-optimize-cancer-treatment https://www.owkin.com/newsfeed/owkin-launches-k-navigator-a-ground-breaking-agentic-co-pilot-to-speed-up-breakthroughs-in-biomedical-research-by-20x https://www.owkin.com/newsfeed/owkin-launches-k-pro-the-first-agentic-ai-co-pilot-for-biopharma-powered-by-biological-reasoning-models https://www.owkin.com/newsfeed/owkin-launches-new-startup-to-capture-laws-of-biology-with-35m-seed-round https://www.owkin.com/newsfeed/owkin-launches-open-science-push-by-open-sourcing-ai-software-substra-and-releasing-two-open-source-ai-innovations-at-neurips https://www.owkin.com/newsfeed/owkin-launches-portrait-a-33-million-project-to-make-france-a-global-leader-in-using-ai-to-diagnose-and-treat-diseases https://www.owkin.com/newsfeed/owkin-melloddy-partners-discuss-how-secure-data-sharing-can-enable-innovation-from-competition-to-collaboration https://www.owkin.com/newsfeed/owkin-named-medtech-visionaries-best-oncology-ai-company-for-precision-medicine https://www.owkin.com/newsfeed/owkin-on-the-front-line-to-model-the-evolution-and-impact-of-the-covid-19-virus https://www.owkin.com/newsfeed/owkin-partners-with-arkhn-and-inria-to-standardize-access-to-health-data-through-oncolab-a-new-eu10-million-project https://www.owkin.com/newsfeed/owkin-partners-with-hopital-foch-to-validate-its-tumor-biomarkers-on-human-biological-samples https://www.owkin.com/newsfeed/owkin-partners-with-institut-pasteur-to-identify-high-immunogenic-epitopes-for-future-coronavirus-vaccines https://www.owkin.com/newsfeed/owkin-partners-with-istituto-europeo-di-oncologia-ieo-to-advance-ai-driven-cancer-research-and-therapeutic-development https://www.owkin.com/newsfeed/owkin-partners-with-leeds-teaching-hospitals-to-drive-forward-medical-research-using-health-data https://www.owkin.com/newsfeed/owkin-powers-a-new-era-in-oncology-research-with-mosaic-an-unprecedented-50-million-spatial-atlas-of-cancer-cells https://www.owkin.com/newsfeed/owkin-presentation-projects-and-future-initiatives https://www.owkin.com/newsfeed/owkin-published-in-nature-communications-a-deep-learning-model-to-predict-rna-seq-expression-of-tumors-from-whole-slide-images https://www.owkin.com/newsfeed/owkin-publishes-breakthrough-research-in-nature-medicine https://www.owkin.com/newsfeed/owkin-raises-11m-for-its-series-a-financing-round https://www.owkin.com/newsfeed/owkin-raises-25m-to-build-a-federated-data-network-for-healthcare-research https://www.owkin.com/newsfeed/owkin-receives-european-medicines-agency-letter-of-support-for-innovative-ai-driven-approach-to-oncology-trial-analysis https://www.owkin.com/newsfeed/owkin-releases-graidient-an-open-source-framework-that-allows-interpretable-deep-learning-models-to-be-created-using-mac-gpus https://www.owkin.com/newsfeed/owkin-rolls-out-its-landmark-ai-diagnostic-within-medipath-the-largest-network-of-pathologists-in-france https://www.owkin.com/newsfeed/owkin-rounds-out-its-series-a-with-another-18m-in-capital https://www.owkin.com/newsfeed/owkin-shares-new-ai-severity-score-for-covid-19-integrating-ct-images-published-to-nature-communications https://www.owkin.com/newsfeed/owkin-showcases-five-ai-abstracts-at-esmo-including-how-deep-learning-can-predict-kras-from-h-e-slides-with-amgen-and-bergonie https://www.owkin.com/newsfeed/owkin-signs-research-agreement-with-genmab-a-s-to-explore-the-biological-profiles-of-cancer-patients-to-improve-treatments https://www.owkin.com/newsfeed/owkin-tackles-the-management-of-breast-and-colon-cancer https://www.owkin.com/newsfeed/owkin-teams-up-with-kings-college-london-and-nvidia-to-build-a-hospital-ai-network-to-boost-uk-healthcare-research https://www.owkin.com/newsfeed/owkin-teams-up-with-neogenomics-and-france-tissue-bank-to-build-ihc-dedicated-foundation-model-for-ai-driven-adc-diagnostics https://www.owkin.com/newsfeed/owkin-the-francis-crick-institute-and-the-royal-marsden-nhs-foundation-trust-are-using-ai-to-research-kidney-cancer-evolution https://www.owkin.com/newsfeed/owkin-to-improve-bile-duct-cancer-treatment-through-new-innovation-collaboration https://www.owkin.com/newsfeed/owkin-unveils-ai-driven-oncology-and-immunology-pipeline-in-licenses-best-in-class-asset-okn4395 https://www.owkin.com/newsfeed/owkin-unveils-europes-first-pan-european-agentic-infrastructure-for-biology-at-the-franco-german-digital-sovereignty-summit https://www.owkin.com/newsfeed/owkin-unveils-new-insights-into-the-opportunities-and-challenges-for-digital-pathology-and-ai-solutions-in-healthcare https://www.owkin.com/newsfeed/owkin-welcomes-political-advisor-yedidia-levy-zauberman-as-svp-of-public-affairs-impact https://www.owkin.com/newsfeed/owkins-ai-model-demonstrates-that-machine-learning-can-predict-gene-expression-across-cancer-types https://www.owkin.com/newsfeed/owkins-breast-cancer-research-is-featured-on-tf1 https://www.owkin.com/newsfeed/owkins-ceo-thomas-clozel-named-in-le-figaros-top-7-french-leaders-in-ai https://www.owkin.com/newsfeed/owkins-deep-learning-model-applied-to-digital-pathology-slides-to-predict-the-relapse-risk-in-invasive-breast-cancer https://www.owkin.com/newsfeed/owkins-msintuit-crc-wins-the-best-medical-technology-prix-galien-award https://www.owkin.com/newsfeed/owkins-specialized-biological-ai-agent-pathology-explorer-launches-with-anthropics-claude-for-healthcare-and-life-sciences https://www.owkin.com/newsfeed/palmares-des-inventeurs-2024-les-laureats-de-la-biotech-comment-mettre-sur-pied-une-medecine-de-precision https://www.owkin.com/newsfeed/partner-spotlight-owkin-and-sanofi-embrace-the-golden-era-of-precision-medicine-with-ai https://www.owkin.com/newsfeed/pharmaceutical-giant-bristol-myers-squibb-invests-80-million-in-owkin-to-advance-drug-trials https://www.owkin.com/newsfeed/pharmaceutical-giants-including-novartis-and-merck-collaborate-to-build-melloddy-a-federated-learning-platform-for-drug-discovery https://www.owkin.com/newsfeed/power-and-significance-enhancing-clinical-trial-benefits-through-ai-driven-covariate-adjustment https://www.owkin.com/newsfeed/salesforce-and-aws-step-up-to-bolster-ai-safety-and-drug-discovery https://www.owkin.com/newsfeed/sanofi-signs-a-270m-strategic-partnership-with-owkin-to-research-new-treatments-across-four-cancers https://www.owkin.com/newsfeed/servier-partners-with-owkin-with-the-aim-of-discovering-and-developing-ai-driven-precision-therapeutics https://www.owkin.com/newsfeed/six-ai-companies-revolutionizing-healthcare-in-2022 https://www.owkin.com/newsfeed/stat-interviews-owkin-svp-andrew-pierce-about-okn4395 https://www.owkin.com/newsfeed/talk-talent-to-me-podcast-interviews-talent-director-helen-burns https://www.owkin.com/newsfeed/tech-for-good-awards-names-owkin-one-of-the-winners-of-the-2021-healthcare-edition https://www.owkin.com/newsfeed/techbio-unicorn-owkin-teams-up-with-aws-to-advance-generative-ai-for-precision-medicine https://www.owkin.com/newsfeed/the-ffcd-and-owkin-join-forces-to-apply-machine-learning-to-digestive-oncology https://www.owkin.com/newsfeed/the-sound-of-your-voice-could-soon-help-doctors-diagnose-diseases https://www.owkin.com/newsfeed/the-us-is-investing-millions-in-ai-to-diagnose-diseases-based-on-the-human-voice https://www.owkin.com/newsfeed/the-white-house-highlights-owkin-and-cancerlinq-collaboration-as-part-of-its-cancer-moonshot https://www.owkin.com/newsfeed/this-ai-startup-founded-by-ex-googlers-just-raised-35-million-check-out-the-12-slide-pitch-deck-bioptimus-used-to-land-the-funds https://www.owkin.com/newsfeed/this-biotech-company-uses-ai-to-enable-doctors-to-share-research-to-cure-diseases https://www.owkin.com/newsfeed/thomas-clozel-on-how-ai-is-helping-to-make-breast-cancer-history https://www.owkin.com/newsfeed/two-first-in-class-ai-diagnostic-solutions-for-breast-cancer-and-colorectal-cancer-developed-by-owkin-are-approved-for-use-in-europe https://www.owkin.com/newsfeed/une-cooperation-franco-allemande-mise-sur-lia-medicale-atout-dans-la-manche-de-leurope https://www.owkin.com/newsfeed/universite-paris-saclay-and-owkin-a-unique-alliance-to-propel-university-medical-research-to-the-top-of-the-european-rankings-thanks-to-ai https://www.owkin.com/newsfeed/vocal-biomarkers-could-soon-help-doctors-diagnose-cancer https://www.owkin.com/newsfeed/wall-street-journal-features-ceo-thomas-clozel https://www.owkin.com/newsfeed/what-is-federated-learning-and-how-it-helps-safeguard-patients-data-in-hospitals https://www.owkin.com/hub-content/academic-partnerships https://www.owkin.com/hub-content/ai-based-identification-of-fgfr3-mutation-status-from-routine-histology-slides-of-muscle-invasive-bladder-cancer https://www.owkin.com/hub-content/brcaura-ruo https://www.owkin.com/hub-content/bring-k-pro-to-your-data https://www.owkin.com/hub-content/can-ai-teach-us-new-features-of-clinical-relevance-in-colorectal-cancers https://www.owkin.com/hub-content/case-study-covariate-adjustment https://www.owkin.com/hub-content/case-study-he2rna https://www.owkin.com/hub-content/case-study-mesonet https://www.owkin.com/hub-content/case-study-msintuit-crc https://www.owkin.com/hub-content/case-study-pacpaint https://www.owkin.com/hub-content/case-study-rlapsrisk-bc https://www.owkin.com/hub-content/case-study-stratification-biomarker https://www.owkin.com/hub-content/case-study-tls-detect https://www.owkin.com/hub-content/data-licencing https://www.owkin.com/hub-content/deep-learning-based-identification-and-characterization-of-her2-low-tumors https://www.owkin.com/hub-content/deep-learning-based-identification-and-characterization-of-her2-low-tumors-2 https://www.owkin.com/hub-content/deep-learning-uncovers-morphological-histological-patterns-of-yap1-tead-activity-related-to-disease-aggressiveness-in-cancer-patients https://www.owkin.com/hub-content/deep-learning-with-wsis-to-predict-histological-response-to-neoadjuvant-chemotherapy-in-patients-with-resectable-high-grade-soft-tissue-sarcomas https://www.owkin.com/hub-content/development-of-a-reproducible-ai-based-spatial-biomarker-of-the-tumor-immune-infiltrate-on-h-e-slides https://www.owkin.com/hub-content/histology-based-prognosis-prediction-using-deep-learning-outperforms-and-is-independent-of-the-mgmt-methylation-status-in-patients-with-glioblastoma https://www.owkin.com/hub-content/k-pro https://www.owkin.com/hub-content/k-pro-for-constultancy https://www.owkin.com/hub-content/k-pro-free https://www.owkin.com/hub-content/k-pro-reports https://www.owkin.com/hub-content/mosaic https://www.owkin.com/hub-content/owkin-powers-a-new-era-in-oncology-research-with-mosaic https://www.owkin.com/hub-content/pathology-explorer https://www.owkin.com/explainer-videos/ai-biotech https://www.owkin.com/explainer-videos/ai-external-control-arms https://www.owkin.com/explainer-videos/ai-powered-biomarkers https://www.owkin.com/explainer-videos/announcing-okn4395 https://www.owkin.com/explainer-videos/covariate-adjustment https://www.owkin.com/explainer-videos/drug-discovery https://www.owkin.com/explainer-videos/drugmatch https://www.owkin.com/explainer-videos/federated-learning-for-healthcare-innovation https://www.owkin.com/explainer-videos/flamby https://www.owkin.com/explainer-videos/humanity https://www.owkin.com/explainer-videos/introducing-owkin https://www.owkin.com/explainer-videos/introducing-owkinzero https://www.owkin.com/explainer-videos/je-suis-elodie https://www.owkin.com/explainer-videos/je-suis-elodie-two-years-on https://www.owkin.com/explainer-videos/jp-morgan-2024-endpoints-panel https://www.owkin.com/explainer-videos/k-pro-drug-positioning-strategy-demo https://www.owkin.com/explainer-videos/k-pro-expert-skills https://www.owkin.com/explainer-videos/k-pro-finding-white-space-indications https://www.owkin.com/explainer-videos/k-pro-full-demo https://www.owkin.com/explainer-videos/k-pro-multimodal-discovery-demo https://www.owkin.com/explainer-videos/k-pro-owkins-agentic-ai-platform-for-pharmaceutical-research https://www.owkin.com/explainer-videos/k-pro-skills-ci-workflows https://www.owkin.com/explainer-videos/mosaic https://www.owkin.com/explainer-videos/owkin-in-partnership-with-jewish-general-hospital https://www.owkin.com/explainer-videos/owkin-x-bsw-partners-in-science https://www.owkin.com/explainer-videos/owkins-adc-capabilities https://www.owkin.com/explainer-videos/owkins-ceo-chats-to-the-ceo-of-insilico-medicine https://www.owkin.com/explainer-videos/professor-miriam-merad-on-precision-medicine-and-owkins-unprecedented-connections https://www.owkin.com/explainer-videos/puls-ai https://www.owkin.com/explainer-videos/securefedyj https://www.owkin.com/explainer-videos/spatial-omics https://www.owkin.com/explainer-videos/sratta https://www.owkin.com/explainer-videos/targetmatch https://www.owkin.com/explainer-videos/targetmatch-owkins-ai-discovery-engine https://www.owkin.com/explainer-videos/tead-explainer https://www.owkin.com/explainer-videos/the-a-to-z-of-ai-in-healthcare https://www.owkin.com/explainer-videos/voice-biomarkers https://www.owkin.com/explainer-videos/what-is-the-c-index https://www.owkin.com/a-z-of-ai-for-healthcare/algorithm https://www.owkin.com/a-z-of-ai-for-healthcare/bias https://www.owkin.com/a-z-of-ai-for-healthcare/c-index https://www.owkin.com/a-z-of-ai-for-healthcare/digital-twin https://www.owkin.com/a-z-of-ai-for-healthcare/ethics https://www.owkin.com/a-z-of-ai-for-healthcare/federated-learning https://www.owkin.com/a-z-of-ai-for-healthcare/generalizability https://www.owkin.com/a-z-of-ai-for-healthcare/harmonization https://www.owkin.com/a-z-of-ai-for-healthcare/imaging-data https://www.owkin.com/a-z-of-ai-for-healthcare/job-enhancement https://www.owkin.com/a-z-of-ai-for-healthcare/knowledge-graphs https://www.owkin.com/a-z-of-ai-for-healthcare/large-language-model https://www.owkin.com/a-z-of-ai-for-healthcare/multimodal-data https://www.owkin.com/a-z-of-ai-for-healthcare/neural-networks https://www.owkin.com/a-z-of-ai-for-healthcare/overfitting https://www.owkin.com/a-z-of-ai-for-healthcare/prediction https://www.owkin.com/a-z-of-ai-for-healthcare/quality-vs-quantity-of-data https://www.owkin.com/a-z-of-ai-for-healthcare/representation https://www.owkin.com/a-z-of-ai-for-healthcare/subgroup-determination https://www.owkin.com/a-z-of-ai-for-healthcare/training https://www.owkin.com/a-z-of-ai-for-healthcare/unsupervised-vs-supervised-learning https://www.owkin.com/a-z-of-ai-for-healthcare/validation https://www.owkin.com/a-z-of-ai-for-healthcare/white-box-vs-black-box https://www.owkin.com/a-z-of-ai-for-healthcare/xai https://www.owkin.com/a-z-of-ai-for-healthcare/you https://www.owkin.com/a-z-of-ai-for-healthcare/zero-shot-learning https://www.owkin.com/blogs-case-studies/aacr-2025-charting-the-future-of-cancer-research-with-spatial-omics-ai-and-plushies https://www.owkin.com/blogs-case-studies/advancing-bowel-cancer-awareness-the-role-of-ai-in-early-detection-and-precision-medicine https://www.owkin.com/blogs-case-studies/ai-driven-target-discovery-its-a-journey https://www.owkin.com/blogs-case-studies/ai-for-glioblastoma-hackathon-a-deep-dive-into-the-winning-solutions https://www.owkin.com/blogs-case-studies/ai-solutions-drive-digital-pathology-transformation-june-conference-insights-from-asco-ecdp-and-rcpath https://www.owkin.com/blogs-case-studies/ai-that-can-predict-which-cancer-patients-are-most-likely-to-discontinue-treatment https://www.owkin.com/blogs-case-studies/alban-fact-checks-chatgpts-views-on-how-generative-ai-will-impact-drug-discovery https://www.owkin.com/blogs-case-studies/alban-owkins-chief-business-officer-discusses-his-four-key-takeaways-to-a-successful-strategic-alliance-between-biotech-and-big-pharma https://www.owkin.com/blogs-case-studies/augmenting-data-scientists-and-biologists-through-the-integration-of-llms-in-drug-discovery https://www.owkin.com/blogs-case-studies/beyond-the-magic-bullet-why-the-future-of-adcs-is-written-in-spatial-biology https://www.owkin.com/blogs-case-studies/bioptimus-the-first-ever-universal-ai-foundation-model-for-biology https://www.owkin.com/blogs-case-studies/blog-1-opportunities-and-obstacles-for-ai-in-pathology https://www.owkin.com/blogs-case-studies/blog-2-the-importance-of-data-in-building-an-ai-diagnostic https://www.owkin.com/blogs-case-studies/blog-3-building-ai-models-from-whole-slide-images https://www.owkin.com/blogs-case-studies/blog-4-from-ai-model-to-validated-medical-device https://www.owkin.com/blogs-case-studies/blog-6-deploying-an-ai-diagnostic https://www.owkin.com/blogs-case-studies/breakthrough-in-medical-research-published-in-nature-medicine https://www.owkin.com/blogs-case-studies/breast-cancer-and-ai-a-discussion-with-pr-fabrice-andre-head-of-research-at-gustave-roussy https://www.owkin.com/blogs-case-studies/bridging-the-gap-between-federated-learning-theory-and-practice-with-real-world-healthcare-datasets https://www.owkin.com/blogs-case-studies/can-an-ai-diagnostic-help-doctors-make-more-precise-treatment-decisions-for-breast-cancer https://www.owkin.com/blogs-case-studies/can-we-trust-ai-when-it-comes-to-biology https://www.owkin.com/blogs-case-studies/case-study-brcaura-ruo https://www.owkin.com/blogs-case-studies/case-study-covariate-adjustment https://www.owkin.com/blogs-case-studies/case-study-he2rna https://www.owkin.com/blogs-case-studies/case-study-k-pro-reports https://www.owkin.com/blogs-case-studies/case-study-mesonet https://www.owkin.com/blogs-case-studies/case-study-msintuit-r-crc https://www.owkin.com/blogs-case-studies/case-study-pacpaint https://www.owkin.com/blogs-case-studies/case-study-pathology-explorer https://www.owkin.com/blogs-case-studies/case-study-rlapsrisk-r-bc https://www.owkin.com/blogs-case-studies/case-study-stratification-biomarker https://www.owkin.com/blogs-case-studies/case-study-tls-detect https://www.owkin.com/blogs-case-studies/cytosyn-a-state-of-the-art-diffusion-model-for-histopathology-image-generation https://www.owkin.com/blogs-case-studies/data-preparation-in-healthcare-part-1 https://www.owkin.com/blogs-case-studies/data-preparation-in-healthcare-part-2 https://www.owkin.com/blogs-case-studies/data-preparation-in-healthcare-part-3 https://www.owkin.com/blogs-case-studies/data-protection-is-a-hard-problem-for-agentic-ai---how-do-we-solve-it https://www.owkin.com/blogs-case-studies/defending-against-attacks-on-federated-learning-using-secure-aggregation https://www.owkin.com/blogs-case-studies/delve-into-the-layers-of-a-deep-learning-model-with-graidient https://www.owkin.com/blogs-case-studies/developing-virtual-staining-at-owkin-to-enrich-digital-pathology https://www.owkin.com/blogs-case-studies/discover-how-old-your-brain-is-with-mri-data-and-artificial-intelligence https://www.owkin.com/blogs-case-studies/diversity-in-stem-3-insider-tips-from-women-in-tech https://www.owkin.com/blogs-case-studies/driving-innovation-in-ai-for-healthcare-owkin-at-the-ai-action-summit https://www.owkin.com/blogs-case-studies/electric-energy-and-emerging-ai https://www.owkin.com/blogs-case-studies/emerging-technologies-like-ai-and-spatial-transcriptomics-are-now-taking-center-stage-insights-from-owkins-director-of-biomarkers-at-aacr-2024 https://www.owkin.com/blogs-case-studies/evaluating-owkins-discovery-ai-model-setting-a-new-standard-in-ai-target-discovery https://www.owkin.com/blogs-case-studies/external-control-arms-a-cutting-edge-methodology-to-de-risk-and-accelerate-clinical-trials https://www.owkin.com/blogs-case-studies/federated-learning-in-healthcare-building-trust-through-traceability https://www.owkin.com/blogs-case-studies/federated-learning-in-healthcare-the-future-of-collaborative-clinical-and-biomedical-research https://www.owkin.com/blogs-case-studies/federated-learning-owkin-at-the-forefront-of-real-world-applications-at-neurips-2022 https://www.owkin.com/blogs-case-studies/federated-learning-scales-real-world-data-access-for-external-control-arms https://www.owkin.com/blogs-case-studies/federated-learning-the-most-effective-collaborative-ai-framework-for-healthcare https://www.owkin.com/blogs-case-studies/five-ways-ai-can-unlock-the-full-potential-of-adcs https://www.owkin.com/blogs-case-studies/five-ways-digital-pathology-is-transforming-healthcare https://www.owkin.com/blogs-case-studies/from-banking-to-big-pharma-to-ai-biotech-alban-de-la-sablieres-take-on-jpm-and-industry-trends https://www.owkin.com/blogs-case-studies/from-foundation-models-to-ai-scientists-inside-oncologys-ai-shift-at-aacr-2026 https://www.owkin.com/blogs-case-studies/getting-it-right-a-mindful-approach-to-healthcare-ai https://www.owkin.com/blogs-case-studies/how-ai-can-make-clinical-trials-faster-more-efficient-and-more-personalised https://www.owkin.com/blogs-case-studies/how-new-drugs-and-ai-are-helping-to-treat-her2-low-breast-cancer-patients https://www.owkin.com/blogs-case-studies/how-owkin-and-cancerlinq-aim-to-improve-lung-cancer-treatment-using-federated-learning https://www.owkin.com/blogs-case-studies/how-owkin-diagnostics-tackles-the-challenge-of-generalizability https://www.owkin.com/blogs-case-studies/how-owkin-k-can-change-a-biotech-workflow https://www.owkin.com/blogs-case-studies/how-spatial-omics-technologies-are-revolutionizing-cancer-research https://www.owkin.com/blogs-case-studies/how-to-develop-a-covid-19-ai-severity-score-in-a-race-against-a-pandemic https://www.owkin.com/blogs-case-studies/how-will-spatial-omics-help-us-fight-cancer-in-the-future https://www.owkin.com/blogs-case-studies/integrating-multimodal-data-to-meet-clinical-challenges https://www.owkin.com/blogs-case-studies/interview-with-charlie-saillard-validating-an-ai-diagnostic https://www.owkin.com/blogs-case-studies/invoke-closing-the-loop-between-ai-prediction-and-clinical-validation https://www.owkin.com/blogs-case-studies/keeping-owkin-secure https://www.owkin.com/blogs-case-studies/key-highlights-and-takeaways-from-owkin-team-at-asco https://www.owkin.com/blogs-case-studies/leveraging-machine-learning-to-optimize-clinical-trials https://www.owkin.com/blogs-case-studies/mapping-the-future-of-rheumatology-owkins-top-takeaways-from-eular-2025 https://www.owkin.com/blogs-case-studies/melloddy-a-co-opetitive-platform-for-machine-learning-across-companies-powered-by-owkin-technology https://www.owkin.com/blogs-case-studies/multimodal-analysis-is-crucial-to-make-novel-medical-discoveries https://www.owkin.com/blogs-case-studies/my-stem-story-celebrating-international-womens-day https://www.owkin.com/blogs-case-studies/one-year-into-the-mosaic-project-key-learnings-from-a-multidisciplinary-cancer-research-project https://www.owkin.com/blogs-case-studies/overcoming-the-challenge-of-heterogeneity-in-healthcare https://www.owkin.com/blogs-case-studies/owkin-ai-model-predicting-survival-of-cancer-patients-from-radiology-and-clinical-data-is-published-in-the-european-journal-of-cancer https://www.owkin.com/blogs-case-studies/owkin-breast-cancer-offering https://www.owkin.com/blogs-case-studies/owkin-expands-in-spain-with-fundacion-instituto-de-investigacion-sanitaria-islas-baleares-idisba-bringing-leading-ai-to-improve-cardiovascular-disease-outcomes https://www.owkin.com/blogs-case-studies/owkin-from-the-inside-discussion-with-thierry-durand-head-of-it-systems-at-centre-leon-berard https://www.owkin.com/blogs-case-studies/owkin-hcc-offering-predicting-prognosis-and-identifying-biomarkers-for-liver-cancer https://www.owkin.com/blogs-case-studies/owkin-in-depth-pushing-boundaries-in-ai-research https://www.owkin.com/blogs-case-studies/owkin-joins-uk-digital-pathology-consortium-pathlake-to-advance-research-and-improve-patient-diagnostics https://www.owkin.com/blogs-case-studies/owkin-manifesto-a-new-frontier-of-medical-research https://www.owkin.com/blogs-case-studies/owkin-receives-ema-letter-of-support-for-innovative-ai-driven-approach-to-oncology-trial-analysis https://www.owkin.com/blogs-case-studies/owkin-to-collaborate-with-sorbonne-university-and-ap-hp-to-optimize-clinical-trials-for-cancer-patients https://www.owkin.com/blogs-case-studies/owkins-aurelie-fugon-shares-her-highlights-from-esmo-2022 https://www.owkin.com/blogs-case-studies/owkins-lab-is-at-the-forefront-of-building-3d-organoids https://www.owkin.com/blogs-case-studies/owkins-wilfried-dang-shares-his-highlights-from-bioeurope-on-the-latest-trends-in-ai-for-drug-discovery https://www.owkin.com/blogs-case-studies/pacpaint-the-path-to-personalized-treatment-for-pancreatic-adenocarcinoma https://www.owkin.com/blogs-case-studies/patient-data-is-full-of-potential-but-dont-data-grab-it-too-tightly https://www.owkin.com/blogs-case-studies/precision-medicine-was-at-the-heart-of-esmo-2023 https://www.owkin.com/blogs-case-studies/predicting-gene-expression-using-our-novel-genomic-analysis-tool-he2rna https://www.owkin.com/blogs-case-studies/predicting-gene-expression-with-machine-learning https://www.owkin.com/blogs-case-studies/prioritizing-family-and-wellbeing-through-our-new-parental-leave-policy https://www.owkin.com/blogs-case-studies/privacy-preserving-machine-learning-to-protect-health-data https://www.owkin.com/blogs-case-studies/professor-miriam-merad-on-precision-medicine-and-owkins-unprecedented-connections https://www.owkin.com/blogs-case-studies/prompt-like-a-pro https://www.owkin.com/blogs-case-studies/pydeseq2-a-new-tool-in-the-python-omics-ecosystem https://www.owkin.com/blogs-case-studies/regulatory-reimbursement-hurdles-in-getting-to-market https://www.owkin.com/blogs-case-studies/revolutionizing-cancer-research-insights-from-owkins-director-of-biomarkers-at-asco-2023 https://www.owkin.com/blogs-case-studies/sean-khozin-on-how-owkin-is-leading-the-ai-revolution-in-medicine https://www.owkin.com/blogs-case-studies/shaping-the-future-of-oncology-key-insights-from-esmo-2024 https://www.owkin.com/blogs-case-studies/spatial-biology-in-drug-discovery-and-development-opportunities-and-challenges https://www.owkin.com/blogs-case-studies/spatial-omics-between-technology-development-and-early-discoveries https://www.owkin.com/blogs-case-studies/story-of-the-1st-federated-learning-model-at-owkin https://www.owkin.com/blogs-case-studies/surfing-the-healthcare-wave-at-icml https://www.owkin.com/blogs-case-studies/tackling-the-challenge-of-normalizing-data-for-machine-learning-while-preserving-privacy https://www.owkin.com/blogs-case-studies/teaching-ai-with-reinforcement-learning-in-a-biology-video-game-to-find-the-root-cause-of-disease https://www.owkin.com/blogs-case-studies/the-importance-of-i-dont-know-thomas-clozels-personal-journey-from-clinician-to-scale-up-co-founder https://www.owkin.com/blogs-case-studies/the-rise-of-agentic-ai-in-cancer-research-highlights-from-esmo-ai https://www.owkin.com/blogs-case-studies/the-role-of-msi-in-cancer-five-key-insights-from-the-national-inter-siric-congress-on-tumors-with-microsatellite-instability https://www.owkin.com/blogs-case-studies/the-spanish-ai-healthcare-landscape https://www.owkin.com/blogs-case-studies/towards-ai-scientists-that-learn-from-the-lab https://www.owkin.com/blogs-case-studies/transfer-learning-in-healthcare-tackling-the-curse-of-dimensionality https://www.owkin.com/blogs-case-studies/ubc-ocean-kaggle-competition-meet-the-winners https://www.owkin.com/blogs-case-studies/unlocking-the-next-era-of-therapeutic-discovery-training-an-agentic-ai-researcher-with-reinforcement-learning https://www.owkin.com/blogs-case-studies/validating-paper-to-skills-double-debiased-machine-learning-case-study https://www.owkin.com/blogs-case-studies/vibing-with-your-research-the-future-of-vibe-research-for-biology https://www.owkin.com/blogs-case-studies/women-in-science-a-sparkling-combination https://www.owkin.com/our-events/aacr-2026 https://www.owkin.com/our-events/aacr-annual-meeting-2024 https://www.owkin.com/our-events/aacr-annual-meeting-2025 https://www.owkin.com/our-events/aacr-sabcs-2025 https://www.owkin.com/our-events/ai-in-oncology-by-ihu-prism https://www.owkin.com/our-events/asco-annual-meeting-2024 https://www.owkin.com/our-events/asco-annual-meeting-2025 https://www.owkin.com/our-events/autm-2025 https://www.owkin.com/our-events/autm-2026 https://www.owkin.com/our-events/belgian-week-of-pathology-2024 https://www.owkin.com/our-events/biotechx-europe-2024 https://www.owkin.com/our-events/biotechx-europe-2025 https://www.owkin.com/our-events/carrefour-pathologie-2024 https://www.owkin.com/our-events/carrefour-pathologie-2025 https://www.owkin.com/our-events/chu-2025 https://www.owkin.com/our-events/chu-healthtech-connexion-day https://www.owkin.com/our-events/digital-pathology-ai-congress https://www.owkin.com/our-events/dp-ai-eu-2025 https://www.owkin.com/our-events/eccb-2025 https://www.owkin.com/our-events/ecp-annual-meeting-2025 https://www.owkin.com/our-events/esmo-ai-digital-oncology-congress-2025 https://www.owkin.com/our-events/esmo-congress-2024 https://www.owkin.com/our-events/esmo-congress-2025 https://www.owkin.com/our-events/european-congress-of-pathology-ecp-2024 https://www.owkin.com/our-events/global-cvct-forum-2024 https://www.owkin.com/our-events/health-tech-global-summit-2026 https://www.owkin.com/our-events/les-rencontres-de-la-cancerologie-francaise https://www.owkin.com/our-events/midl-2024 https://www.owkin.com/our-events/rlapsrisk-bc-webinar-breast-cancer-recurrence-risk-assessment-from-digitized-h-e https://www.owkin.com/our-events/san-antonio-breast-cancer-symposium-2024 https://www.owkin.com/our-events/seom-congress-2024 https://www.owkin.com/our-events/state-of-the-nation https://www.owkin.com/our-events/transforming-digital-pathology-ai https://www.owkin.com/our-events/uscap-2025 https://www.owkin.com/our-events/uscap-2026 https://www.owkin.com/our-events/world-cb-cdx-2024 https://www.owkin.com/our-events/world-cb-cdx-summit https://www.owkin.com/conference-posters/a-lightweight-ihc-specific-foundation-model-for-diagnostic-purposes https://www.owkin.com/conference-posters/accelerer-la-medecine-de-precision-en-oncologie-grace-a-un-workflow-efficace-de-la-collecte-et-de-la-re-utilisation-secondaire-des-donnees-patient-multimodales-et-multicentriques https://www.owkin.com/conference-posters/ai-agent-for-pharma-r-d-powering-nextgen-drug-discovery-development https://www.owkin.com/conference-posters/ai-driven-microsatellite-instability-testing-in-gastric-and-endometrial-cancers-towards-reflex-testing https://www.owkin.com/conference-posters/ai-for-drug-development-and-discovery https://www.owkin.com/conference-posters/ai-for-histology-based-spatial-biomarker-discovery https://www.owkin.com/conference-posters/ai-for-histology-based-spatial-biomarker-discovery-2 https://www.owkin.com/conference-posters/beyond-crc-ai-powered-msi-status-detection-across-gastric-endometrial-biliary-tract-cancers https://www.owkin.com/conference-posters/cell-level-staining-quantification-framework-for-her2-prediction https://www.owkin.com/conference-posters/clinical-grade-ai-model-to-streamline-msi-testing-an-external-and-multicentric-validation-study https://www.owkin.com/conference-posters/comparative-efficacy-of-folfirinox-versus-gemcitabine-plus-nab-paclitaxel-in-metastatic-pancreatic-cancer https://www.owkin.com/conference-posters/comparative-performance-of-an-ai-based-digital-pathology-tool-and-genomic-signatures-in-early-er-her2--breast-cancer https://www.owkin.com/conference-posters/context-based-drug-positioning-and-multimodal-characterization-for-okn4395 https://www.owkin.com/conference-posters/deep-learning-tertiary-lymphoid-structures-detection-on-hes-h-e-slides-and-association-to-survival-outcome-in-sarcoma https://www.owkin.com/conference-posters/development-and-validation-of-an-ai-model-for-predicting-germline-brca1-2-mutations-from-hr-her2--breast-cancer-histology-images https://www.owkin.com/conference-posters/development-and-validation-of-brcaura-a-histology-model-to-predict-germline-brca1-2-mutations-from-hr-her2--breast-cancer-images https://www.owkin.com/conference-posters/development-of-a-reproducible-ai-based-spatial-biomarker-of-the-tumor-immune-infiltrate-on-h-e-slides https://www.owkin.com/conference-posters/development-validation-and-clinical-usability-of-brcaura https://www.owkin.com/conference-posters/digital-pathology-ai-in-pharma https://www.owkin.com/conference-posters/digital-pathology-and-ai---from-drug-development-to-clinical-in-vitro-diagnostics https://www.owkin.com/conference-posters/fine-grained-inflammatory-cell-segmentation-in-histopathology-with-deep-learning https://www.owkin.com/conference-posters/foundation-model-distillation-to-develop-robust-and-efficient-ai-models-for-msi-testing-in-endometrial-cancer https://www.owkin.com/conference-posters/harnessing-spatial-biology-ai-to-optimize-adc-clinical-development-strategies https://www.owkin.com/conference-posters/harnessing-spatial-biology-and-agentic-ai-to-optimize-adc-clinical-development-strategies https://www.owkin.com/conference-posters/how-ai-can-help-understand-early-stage-hcm https://www.owkin.com/conference-posters/improving-model-generalization-to-out-of-domain-data-in-histopathology-leveraging-simple-techniques-for-external-validation https://www.owkin.com/conference-posters/invoke-a-phase-1-study-of-okn4395-a-first-in-class-ep2-ep4-dp1-triple-prostanoid-receptor-antagonist-in-patients-with-advanced-solid-tumors https://www.owkin.com/conference-posters/la-preparation-des-lames-de-coloration-standard-a-lepreuve-de-la-numerisation-et-de-lia-votre-technique-est-elle-prete https://www.owkin.com/conference-posters/leveraging-ai-diagnostics-for-digital-pathology-biomarker-screening-and-patient-outcome-prediction-from-clinical-trials-to-clinical-routine https://www.owkin.com/conference-posters/mosaic-window-spatial-intra-tumoral-heterogeneity-characterization-through-large-scale-spatial-and-single-nuclei-multi-omics-profiling https://www.owkin.com/conference-posters/optimisation-du-depistage-msi-sur-lames-histologiques-h-e-de-biopsies-de-cancer-colorectal-par-un-modele-dintelligence-artificielle https://www.owkin.com/conference-posters/optimizing-msi-testing-with-ai-using-he-histology-slides-of-colorectal-cancer-biopsies https://www.owkin.com/conference-posters/organizational-impact-of-an-ai-based-pre-screening-tool-for-the-diagnosis-of-mmr-msi-status-in-patients-with-colorectal-cancer https://www.owkin.com/conference-posters/pathomics-prediction-of-thymic-epithelial-tumors-histological-subtypes-the-ai-tet-study https://www.owkin.com/conference-posters/pharos-a-real-world-multi-country-european-study-on-patients-with-high-risk-localised-and-locally-advanced-prostate-cancer-receiving-radical-treatment https://www.owkin.com/conference-posters/quantifying-hallmarks-of-adc-response-and-toxicity-through-ai-powered-analysis-of-the-multi-omics-spatial-atlas-in-cancer-mosaic https://www.owkin.com/conference-posters/rethinking-drug-r-d-building-ai-for-biological-reasoning https://www.owkin.com/conference-posters/towards-achieving-full-msi-reflex-testing-in-crc-gc-and-ec-an-efficient-and-streamlined-approach-using-deep-learning https://www.owkin.com/conference-posters/transforming-image-into-action-for-precision-oncology-with-ai https://www.owkin.com/conference-posters/une-solution-dia-pour-la-detection-des-tls-a-partir-de-lames-h-e-numeriques-peut-elle-ouvrir-la-voie-a-une-meilleure-comprehension-du-microenvironnement-tumoral https://www.owkin.com/science-advent/1 https://www.owkin.com/science-advent/10 https://www.owkin.com/science-advent/11 https://www.owkin.com/science-advent/12 https://www.owkin.com/science-advent/2 https://www.owkin.com/science-advent/3 https://www.owkin.com/science-advent/4 https://www.owkin.com/science-advent/5 https://www.owkin.com/science-advent/6 https://www.owkin.com/science-advent/7 https://www.owkin.com/science-advent/8 https://www.owkin.com/science-advent/9 https://www.owkin.com/faqs/are-external-experts-or-the-academic-community-involved-in-shaping-the-development-of-k-pro https://www.owkin.com/faqs/can-anyone-see-the-data-i-upload-to-k-pro https://www.owkin.com/faqs/can-i-access-new-datasets-through-k-pro https://www.owkin.com/faqs/can-i-access-the-codebase-and-decision-making-process-of-k-pro https://www.owkin.com/faqs/can-i-use-k-pro-with-my-own-data-can-i-upload-my-own-data https://www.owkin.com/faqs/do-you-own-your-full-end-to-end-tech-stack-and-if-not-how-do-you-vet-your-vendors-to-ensure-they-have-the-same-commitment-protecting-data-as-owkin-does https://www.owkin.com/faqs/doesnt-giving-an-ai-this-much-scientific-scope-risk-displacing-whole-research-teams https://www.owkin.com/faqs/how-can-i-analyze-data-from-specific-patient-populations https://www.owkin.com/faqs/how-can-i-report-an-issue-with-the-tool https://www.owkin.com/faqs/how-can-patients-exercise-their-rights https://www.owkin.com/faqs/how-can-you-be-sure-that-k-pro-will-always-be-used-for-good-is-there-potential-for-it-to-be-used-for-nefarious-purposes https://www.owkin.com/faqs/how-do-i-know-i-can-trust-the-results-that-k-pro-produces https://www.owkin.com/faqs/how-do-i-start-with-k-pro https://www.owkin.com/faqs/how-do-we-measure-prevent-hallucinations https://www.owkin.com/faqs/how-do-we-standardize-harmonize-diverse-datasets-and-turn-them-into-a-productized-agentic-system-not-just-prompts https://www.owkin.com/faqs/how-do-you-make-sure-that-the-scientific-conclusions-generated-by-k-pro-are-evidence-based-and-accountable https://www.owkin.com/faqs/how-does-k-pro-integrate-into-existing-it-systems https://www.owkin.com/faqs/how-does-k-pro-protect-confidential-data https://www.owkin.com/faqs/how-does-owkin-ensure-data-security https://www.owkin.com/faqs/how-does-owkin-prevent-bias-in-k-pros-recommendations https://www.owkin.com/faqs/how-is-k-pro-different-from-other-llms https://www.owkin.com/faqs/how-mature-is-agentic-ai-for-pharmaceutical-use https://www.owkin.com/faqs/how-much-investment-has-owkin-recieved https://www.owkin.com/faqs/how-would-different-llms-or-versions-of-the-same-llm-affect-final-outcomes https://www.owkin.com/faqs/is-the-idea-of-biological-artificial-superintelligence-ethically-responsible https://www.owkin.com/faqs/isnt-there-a-risk-of-misuse-if-the-ai-can-act-agentically-how-does-owkin-ensure-responsible-use-of-agentic-capabilities-in-ai https://www.owkin.com/faqs/what-are-the-measures-implemented-by-owkin-and-its-partners-to-ensure-the-security-of-the-processing-of-patient-data https://www.owkin.com/faqs/what-are-the-purposes-for-which-owkin-and-its-partners-could-process-patient-data https://www.owkin.com/faqs/what-are-the-rights-of-patients-when-their-data-is-processed-by-owkin-or-its-partners https://www.owkin.com/faqs/what-can-k-pro-do https://www.owkin.com/faqs/what-do-the-mosaic-and-mosaic-window-datasets-include https://www.owkin.com/faqs/what-is-a-katalyst-session https://www.owkin.com/faqs/what-is-k-pro https://www.owkin.com/faqs/what-is-owkins-founding-story https://www.owkin.com/faqs/what-is-the-list-of-public-and-private-datasets-available-in-k-pro https://www.owkin.com/faqs/what-makes-owkin-different https://www.owkin.com/faqs/where-is-owkin-based https://www.owkin.com/use-cases/clinical-trial-decisions https://www.owkin.com/use-cases/early-portfolio-decisions https://www.owkin.com/use-cases/patient-population-decisions